scispace - formally typeset
A

Armando Córdova

Researcher at Mid Sweden University

Publications -  311
Citations -  13750

Armando Córdova is an academic researcher from Mid Sweden University. The author has contributed to research in topics: Enantioselective synthesis & Catalysis. The author has an hindex of 68, co-authored 303 publications receiving 12969 citations. Previous affiliations of Armando Córdova include Scripps Research Institute & Stockholm University.

Papers
More filters
Journal ArticleDOI

Highly Enantioselective Control of Dynamic Cascade Transformations by Dual Catalysis : Asymmetric Synthesis of Polysubstituted Spirocyclic Oxindoles

TL;DR: The highly enantioselective (up to >99.5:0.5 er) synthesis of polysubstituted spirocyclic oxindoles with four new contiguous stereocenters with spiro all-carbon quaternary center is presented.
Journal ArticleDOI

A concise enantioselective synthesis of iminosugar derivatives

TL;DR: The four stereocenters of the iminosugar derivatives are created in two-steps with high chemoselectivity and excellent enantioselectivities.
Journal ArticleDOI

Organocatalytic highly enantioselective α-selenenylation of aldehydes

TL;DR: In this article, the highly enantioselective organocatalytic α-selenenylation of aldehydes is presented, which gives access to α-phenylselenoaldehydes and β-selenoalcohols in high yields with up to >99% ee.
Journal ArticleDOI

Asymmetric Synthesis of Maraviroc (UK-427,857)

TL;DR: In this article, an asymmetric synthesis of Maraviroc (UK-427,857), a chemochine receptor 5 (CCR-5) receptor antagonist, based on an expeditious organocatalytic enantioselective assembly of the chiral β-amino aldehyde key fragment is presented.
Journal ArticleDOI

Highly Enantioselective Organocatalytic Addition of Aldehydes to N-(Phenylmethylene)benzamides : Asymmetric Synthesis of the Paclitaxel Side Chain and Its Analogues

TL;DR: Easily side-tracked: A simple route to the paclitaxel side chain and its analogues is based on the (R)-proline-catalyzed addition of aldehydes to N-(phenylmethylene)benzamides, followed by oxidation of the resulting protected alpha-hydroxy-beta-benzoylaminoaldehydes.